292 related articles for article (PubMed ID: 30623593)
1. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients.
Panigrahi GK; Praharaj PP; Kittaka H; Mridha AR; Black OM; Singh R; Mercer R; van Bokhoven A; Torkko KC; Agarwal C; Agarwal R; Abd Elmageed ZY; Yadav H; Mishra SK; Deep G
Cancer Med; 2019 Mar; 8(3):1110-1123. PubMed ID: 30623593
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells.
Panigrahi GK; Praharaj PP; Peak TC; Long J; Singh R; Rhim JS; Abd Elmageed ZY; Deep G
Sci Rep; 2018 Mar; 8(1):3853. PubMed ID: 29497081
[TBL] [Abstract][Full Text] [Related]
3. Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer.
Panigrahi GK; Deep G
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1682-1696. PubMed ID: 28410139
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.
Turay D; Khan S; Diaz Osterman CJ; Curtis MP; Khaira B; Neidigh JW; Mirshahidi S; Casiano CA; Wall NR
Cancer Invest; 2016; 34(1):1-11. PubMed ID: 26536157
[TBL] [Abstract][Full Text] [Related]
5. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.
Dai L; Li J; Xing M; Sanchez TW; Casiano CA; Zhang JY
Prostate; 2016 Nov; 76(15):1375-86. PubMed ID: 27418398
[TBL] [Abstract][Full Text] [Related]
6. Cell line modeling to study biomarker panel in prostate cancer.
NickKholgh B; Fang X; Winters SM; Raina A; Pandya KS; Gyabaah K; Fino N; Balaji KC
Prostate; 2016 Feb; 76(3):245-58. PubMed ID: 26764245
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
8. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.
Sanchez TW; Zhang G; Li J; Dai L; Mirshahidi S; Wall NR; Yates C; Wilson C; Montgomery S; Zhang JY; Casiano CA
Mol Cell Proteomics; 2016 Dec; 15(12):3564-3580. PubMed ID: 27742740
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
Duijvesz D; Burnum-Johnson KE; Gritsenko MA; Hoogland AM; Vredenbregt-van den Berg MS; Willemsen R; Luider T; Paša-Tolić L; Jenster G
PLoS One; 2013; 8(12):e82589. PubMed ID: 24391718
[TBL] [Abstract][Full Text] [Related]
10. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
11. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
Liu P; Wang W; Wang F; Fan J; Guo J; Wu T; Lu D; Zhou Q; Liu Z; Wang Y; Shang Z; Chan FL; Yang W; Li X; Zhao SC; Zheng Q; Wang F; Wu D
J Transl Med; 2023 Jan; 21(1):40. PubMed ID: 36681849
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.
Koochekpour S; Willard SS; Shourideh M; Ali S; Liu C; Azabdaftari G; Saleem M; Attwood K
Int J Biol Sci; 2014; 10(8):834-45. PubMed ID: 25076860
[TBL] [Abstract][Full Text] [Related]
13. Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.
Myers JS; Vallega KA; White J; Yu K; Yates CC; Sang QA
BMC Cancer; 2017 Jul; 17(1):480. PubMed ID: 28697756
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label-free mass spectrometry.
Adeola HA; Soares NC; Paccez JD; Kaestner L; Blackburn JM; Zerbini LF
Proteomics Clin Appl; 2015 Jun; 9(5-6):597-609. PubMed ID: 25708745
[TBL] [Abstract][Full Text] [Related]
15. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
[TBL] [Abstract][Full Text] [Related]
16. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS; Nair SS; Chakravarty D; Tewari AK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1340. PubMed ID: 33599076
[TBL] [Abstract][Full Text] [Related]
17. The proteomics of prostate cancer exosomes.
Drake RR; Kislinger T
Expert Rev Proteomics; 2014 Apr; 11(2):167-77. PubMed ID: 24564711
[TBL] [Abstract][Full Text] [Related]
18. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
McKiernan J; Donovan MJ; Margolis E; Partin A; Carter B; Brown G; Torkler P; Noerholm M; Skog J; Shore N; Andriole G; Thompson I; Carroll P
Eur Urol; 2018 Dec; 74(6):731-738. PubMed ID: 30237023
[TBL] [Abstract][Full Text] [Related]
20. Size Dependent Lipidomic Analysis of Urinary Exosomes from Patients with Prostate Cancer by Flow Field-Flow Fractionation and Nanoflow Liquid Chromatography-Tandem Mass Spectrometry.
Yang JS; Lee JC; Byeon SK; Rha KH; Moon MH
Anal Chem; 2017 Feb; 89(4):2488-2496. PubMed ID: 28192938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
